Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* England's month-long lockdown could be extended, Gove says* Health service would be overwhelmed without action now - Gove* Details of financial support to be announced in coming days* Labour's Starmer says UK spurned chance to lockdown earlier* ...
Read more* England's month-long lockdown could be extended, Gove says* Health service would be overwhelmed without action now - Gove* Details of financial support to be announced in coming days* Labour's Starmer says UK spurned chance to lockdown earlier ...
Read moreLONDON, Oct 31 (Reuters) - The United Kingdom on Saturday passed one million confirmed COVID-19 cases, a new milestone as the government considers a new national lockdown in England."Between 31 January and 31 October 2020, there have been 1,011,66...
Read moreLONDON, Oct 31 (Reuters) - British Prime Minister Boris Johnson will impose a new month-long national lockdown in England until Dec. 2, ITV's political editor said on Saturday.All but essential shops will be asked to close and people should no lon...
Read more(Adds Astra comment, background on U.S. government supply contract)ZURICH/FRANKFURT, Oct 30 (Reuters) - AstraZeneca has enlisted contract manufacturer Lonza to produce a combination of two antibodies that may help prevent and treat COVID-19, part...
Read more
(Sharecast News) - Britain's drug regulator has reportedly started an accelerated reviews of Covid-19 vaccines under development from Pfizer and AstraZeneca.
Read moreNAIROBI, Oct 30 (Reuters) - Kenya has joined the global clinical trial of Oxford University's vaccine candidate against the new coronavirus, the state medical research institute said on Friday.The vaccine candidate, known as ChAdOx1 nCoV-19, has b...
Read more* STOXX on track for worst month since March* Miners down after Glencore results* Oil and gas stock index leads gains* Ubisoft shares slump as the game maker cuts its FY guidance Welcome to the home for real-time coverage of markets brought to you...
Read more* STOXX on track for worst month since March* Miners down after Glencore results* Oil and gas stock index leads gains* Ubisoft shares slump as the game maker cuts its FY guidance Welcome to the home for real-time coverage of markets brought to you...
Read more
AstraZeneca Sells Atacand Rights; Lonza To Manufacture Covid Vaccine
Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comBANKS UP, TECH AND BASIC MATERIALS DOWN (0855 GMT)European equity are in negative t...
Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comON THE RADAR: TOTAL, SWISS RE, SPANISH BANKS (0738 GMT)European stocks are set to o...
Read more(Adds background, shares)Oct 30 (Reuters) - AstraZeneca Plc said on Friday it would sell commercial rights for two of its drugs to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer medicines in new t...
Read more(Adds more comments, context)BUDAPEST, Oct 30 (Reuters) - Hungary's first shipment of coronavirus vaccine is expected to arrive in late December or early January, Prime Minister Viktor Orban told state radio on Friday.Orban said Hungary was talkin...
Read more(Sharecast News) - AstraZeneca said it was selling the commercial rights to its heart failure and hypertension drug Atacand and Atacand Plus in around 70 countries globally to Cheplapharm Arzneimittel for $400m.
Read more
Last checked at